Glycation End Products, Advanced
"Glycation End Products, Advanced" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A heterogeneous group of compounds derived from rearrangements, oxidation, and cross-linking reactions that follow from non-enzymatic glycation of amino groups in proteins. They are also know as Maillard products. Their accumulation in vivo accelerates under hyperglycemic, oxidative, or inflammatory conditions. Heat also accelerates the formation of advanced glycation end products (AGEs) such seen with the browning of food during cooking under or over high heat.
| Descriptor ID |
D017127
|
| MeSH Number(s) |
D12.776.643.500
|
| Concept/Terms |
Glycation End Products, Advanced- Glycation End Products, Advanced
- Maillard Reaction End Products
- Maillard Reaction Products
- Products, Maillard Reaction
- Reaction Products, Maillard
- Advanced Maillard Reaction End Products
- Glycation Endproducts, Advanced
- Endproducts, Advanced Glycation
- Glycosylation End Products, Advanced
- Advanced Glycosylation Endproducts
- Endproducts, Advanced Glycosylation
- Glycosylation Endproducts, Advanced
- Advanced Glycation End Products
- Advanced Glycosylation End Products
- Maillard Products
- Products, Maillard
- Advanced Glycation Endproducts
|
Below are MeSH descriptors whose meaning is more general than "Glycation End Products, Advanced".
Below are MeSH descriptors whose meaning is more specific than "Glycation End Products, Advanced".
This graph shows the total number of publications written about "Glycation End Products, Advanced" by people in this website by year, and whether "Glycation End Products, Advanced" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 1996 | 1 | 1 | 2 |
| 1997 | 1 | 1 | 2 |
| 1999 | 0 | 1 | 1 |
| 2002 | 2 | 0 | 2 |
| 2003 | 1 | 1 | 2 |
| 2004 | 0 | 2 | 2 |
| 2005 | 2 | 4 | 6 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 2 | 2 |
| 2008 | 1 | 1 | 2 |
| 2009 | 2 | 1 | 3 |
| 2010 | 3 | 1 | 4 |
| 2011 | 2 | 1 | 3 |
| 2012 | 3 | 3 | 6 |
| 2013 | 2 | 2 | 4 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 1 | 2 |
| 2016 | 2 | 1 | 3 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 2 | 0 | 2 |
| 2021 | 2 | 1 | 3 |
| 2022 | 0 | 1 | 1 |
| 2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Glycation End Products, Advanced" by people in Profiles.
-
Characterizing Dietary Advanced Glycation End-Product (dAGE) Exposure and the Relationship to Colorectal Adenoma Recurrence: A Secondary Analysis. Nutrients. 2023 Feb 23; 15(5).
-
Role and Therapeutic Potential of RAGE Signaling in Neurodegeneration. Curr Drug Targets. 2022; 23(12):1191-1209.
-
Skin autofluorescence is associated with progression of kidney disease in type 2 diabetes: A prospective cohort study from the Hong Kong diabetes biobank. Nutr Metab Cardiovasc Dis. 2022 02; 32(2):436-446.
-
Dietary Advanced Glycation End-Products and Mortality after Breast Cancer in the Women's Health Initiative. Cancer Epidemiol Biomarkers Prev. 2021 12; 30(12):2217-2226.
-
Examination of the Effectiveness of the Healthy Empowered Active Lifestyles (HEAL) Program on Advanced Glycation End Products. Int J Environ Res Public Health. 2021 05 02; 18(9).
-
Dietary Advanced Glycation End-products (AGE) and Risk of Breast Cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial (PLCO). Cancer Prev Res (Phila). 2020 07; 13(7):601-610.
-
Dietary advanced glycation end products and the risk of postmenopausal breast cancer in the National Institutes of Health-AARP Diet and Health Study. Cancer. 2020 06 01; 126(11):2648-2657.
-
Immune Complexes and the Risk of CVD in Type 1 Diabetes. Diabetes. 2019 09; 68(9):1853-1860.
-
Advanced glycation end products are elevated in estrogen receptor-positive breast cancer patients, alter response to therapy, and can be targeted by lifestyle intervention. Breast Cancer Res Treat. 2019 Feb; 173(3):559-571.
-
Abundance, localization, and functional correlates of the advanced glycation end-product carboxymethyl lysine in human myocardium. Physiol Rep. 2017 Nov; 5(20).